Transgenomic Closes Bridge Financing

Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. (April 17, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC,... Read more

Twist Bioscience Expands Agreement to Pursue Higher Density Digital Data Storage on DNA with Microsoft and University of Washington

SAN FRANCISCO, Calif. – April 17, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced Microsoft Corp. will purchase ten million strands of DNA from Twist Bioscience for expanded digital data storage research. The strands of DNA will be long-chain oligonucleotides used by researchers at Microsoft and... Read more

Leica Microsystems Expands EM Sample Prep Coverage through NCI Inc.

BUFFALO GROVE, Ill., April 14, 2017 /PRNewswire/ — Leica Microsystems, a technology leader with a 160-year history of providing best-in-class precision microscopy, electron microscopy (EM) sample preparation and digital micro-imaging solutions, announces a strategic expansion in its market representation in the Midwest and Western regions of the United States. NCI Inc. (formerly North Central Instruments) of... Read more

Hamilton Robotics Collaborates with Illumina in the European Union for Streamlined Noninvasive Prenatal Testing Solution

Automated Whole-Genome Sequencing Approach Provides Confidence in Results with Increased Sample Throughput and Decreased Turnaround Time Reno, Nev. (April13, 2017) – Hamilton Robotics continues to strengthen their ongoing partnership with Illumina, Inc. through the collaborative development of the VeriSeq™ NIPT Solution for high-throughput noninvasive prenatal testing (NIPT). This automated, next-generation sequencing (NGS) workflow is a... Read more

FDA Signs Collaborative Agreement with Emulate, Inc. to Use Organs-on-Chips Technology as a Toxicology Testing Platform for Understanding How Products Affect Human Health and Safety

April 11, 2017 Cooperative Research and Development Agreement (CRADA) to advance and qualify ‘Human Emulation System’ to meet regulatory evaluation criteria for product testing BOSTON, Mass., April 11, 2017 — Emulate, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration’s (FDA) Office... Read more

GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies

Chalfont St Giles, UK – 11 April 2017 – GE Healthcare has acquired Asymptote Limited, specialists in cryochain technology for sensitive cellular therapies. Asymptote’s integrated suite of cryochain hardware, software and consumables are designed to maintain the potency of cellular therapies enabling ultra-low temperature freezing during production, all the way to thawing at the clinic... Read more

GE Healthcare invests in Zenith Technologies, the companies to deliver together next-generation of biopharma automation

CHALFONT ST. GILES, UK and CORK, IRELAND – 11 April 2017 – Zenith Technologies and GE Healthcare Life Sciences announce today that GE has completed a strategic minority investment in Irish-owned Zenith Technologies, a leading technology company delivering manufacturing software systems and solutions for the life sciences industry. This enhancement of the existing partnership brings... Read more

VWR Acquires MESM Ltd.

Acquisition further expands VWRCATALYST Services for Clinical Trial Studies RADNOR, Pa., April 7, 2017 /PRNewswire/ — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, announced today that it has acquired MESM Ltd., a provider of laboratory and medical equipment and ancillary supplies to clinical trials... Read more

Smiths Group announces completion of acquisition of Morpho Detection

7 Apr 2017  Print this page Following the clearance from US Department of Justice on March 31st 2017 Smiths Group plc today confirms that it has completed the acquisition of Morpho Detection. Consistent with the clearance from the European Commission, the DOJ approval is conditional on the post-completion divestment of Morpho Detection’s explosive trace detection... Read more